The Patent Finder
CY

Cytosorbents Corporation

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

25 patents currently held

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Apr 2031. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Apr 2031
Next term end
15
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents fee due within 90 days all others Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Multi-Functional Hemocompatible Porous Polymer Bead Sorbent for Removing Protein Based Toxins and Potassium from Biological Fluids US 11,040,061
Cited by 23 later US patents, top 10% of utility patents granted in 2021 in our data. Protection runs to 2036.
Ends Oct 2036 · High confidence
Also notable
Method of Treating Inflammation US 9,717,755
Cited by 26 later US patents, top 25% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2032.
Ends Nov 2032 · High confidence
Also notable
Hemocompatibility Modifiers for Cross-Linked Polymeric Material US 11,752,250
Cited by 3 later US patents, top 25% of utility patents granted in 2023 in our data. Protection runs to 2034.
Ends Aug 2034 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 11, 2026
    The maintenance fee for Use Of Gastrointestinally Administered Porous Enteron Sorbent Polymers To Prevent Or Treat Radiation Induced Mucositis, Esophagitis, Enteritis, Colitis, And Gastrointestinal Acute Radiation Syndrome (US 10,314,859) comes due Dec 11, 2026. Unpaid by Jun 11, 2027, it lapses early.
  • 1 fee due Feb 15, 2027
    The maintenance fee for Multi-Functional Hemocompatible Porous Polymer Bead Sorbent For Removing Protein Based Toxins And Potassium From Biological Fluids (US 11,723,916) comes due Feb 15, 2027. Unpaid by Aug 16, 2027, it lapses early.
  • 1 fee due Mar 12, 2027
    The maintenance fee for Hemocompatibility Modifiers for Cross-Linked Polymeric Material (US 11,752,250) comes due Mar 12, 2027. Unpaid by Sep 13, 2027, it lapses early.
  • 1 fee due Apr 1, 2027
    The maintenance fee for Polymeric Sorbent for Removal of Impurities from Whole Blood and Blood Products (US 10,426,158) comes due Apr 1, 2027. Unpaid by Oct 1, 2027, it lapses early.
  • 1 fee due May 28, 2027
    The maintenance fee for Use Of A Hemocompatible Porous Polymer Bead Sorbent For Removal Of Endotoxemia-Inducing Molecules (US 11,826,724) comes due May 28, 2027. Unpaid by Nov 29, 2027, it lapses early.
  • 1 fee due Oct 30, 2027
    The maintenance fee for Connector Assembly and Methods of Use (US 11,969,535) comes due Oct 30, 2027. Unpaid by May 1, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 23, 2026
  • 3 terms have ended since Aug 23, 2026

What they patent

The largest of its 15 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Method of Treating Inflammation5 in forceto Nov 2032
Multi-Functional Hemocompatible Porous Polymer Bead Sorbent for Removing Protein Based Toxins and Potassium from Biological Fluids3 in forceto Oct 2036
Use of a Hemocompatible Porous Polymer Bead Sorbent for Removal of Endotoxemia-Inducing Molecules2 in forceto Dec 2037
Use of Gastrointestinally Administered Porous Enteron Sorbent Polymers to Prevent or Treat Radiation Induced Mucositis, Esophagitis, Enteritis, Colitis, and Gastrointestinal Acute Radiation Syndrome2 in forceto Oct 2035
Hemocompatibility Modifiers for Cross-Linked Polymeric Material2 in forceto Aug 2034

Patents held now

Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 10,034,894Method of Treating Inflammation
In force
 · High confidence
In forceHigh confidence
US 10,946,040Method of Treating Inflammation
In force
 · Medium confidence
In forceMedium confidence
US 10,967,001Method of Treating Inflammation
In force
 · Medium confidence
In forceMedium confidence
US 11,058,715Method of Treating Inflammation
In force
 · High confidence
In forceHigh confidence
US 10,064,406Polymeric Sorbent for Removal of Impurities From Whole Blood and Blood Products
In force
 · High confidence
In forceHigh confidence
US 9,717,755Method of Treating Inflammation
In force
 · High confidence
In forceHigh confidence
US 12,280,196Methods of Using Polymers
In force
 · Low confidence
In forceLow confidence
US 11,020,521Hemocompatibility Modifiers for Cross-Linked Polymeric Material
In force
 · High confidence
In forceHigh confidence
US 11,602,585Methods for Reducing Contamination in a Biological Substance
In force
 · Low confidence
In forceLow confidence
US 11,752,250Hemocompatibility Modifiers for Cross-Linked Polymeric Material
In force
 · High confidence
In forceHigh confidence
10 of 25 patents shown.
Pro members see all 25.
Pro members: see all 25 patents
Also on record, not counted in the 25: 14 patents ended · 3 applications pending · 12 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited